Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Cerebral hypoperfusion
|
disease |
|
Disease or Syndrome
|
40
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Progression of prostate cancer
|
disease |
|
Neoplastic Process
|
398
|
7
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Soluble Transferrin Receptor Measurement
|
phenotype |
|
Laboratory Procedure
|
7
|
7
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Fatty Liver Disease
|
disease |
|
Disease or Syndrome
|
741
|
81
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Anisocytosis
|
phenotype |
|
Finding
|
16
|
1
|
0.100 |
None |
|
0 |
|
|
|
Poikilocytosis
|
phenotype |
|
Finding
|
14
|
|
0.100 |
None |
|
0 |
|
|
|
Anisocyte Measurement
|
phenotype |
|
Laboratory Procedure
|
15
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the intestine
|
phenotype |
|
Finding
|
19
|
|
0.100 |
None |
|
0 |
|
|
|
Hyperkeratosis, CTCAE
|
phenotype |
|
Finding
|
87
|
|
0.100 |
None |
|
0 |
|
|
|
Elevated hepcidin level
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2011 |
Depressed mood
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1461
|
269
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2011 |
Androgen-Insensitivity Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
247
|
176
|
0.030 |
None |
1.000 |
3 |
|
2011 |
2016 |
Thalassemia
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
136
|
18
|
0.030 |
None |
1.000 |
3 |
1
|
2013 |
2017 |
Beta thalassemia intermedia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
37
|
12
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2018 |
Hamartoma Syndrome, Multiple
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
270
|
139
|
0.010 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Down Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
766
|
80
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
HEMOCHROMATOSIS, TYPE 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
83
|
62
|
0.060 |
None |
1.000 |
6 |
5
|
2011 |
2019 |
Hemochromatosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
93
|
45
|
0.040 |
None |
1.000 |
4 |
3
|
2011 |
2019 |
Hereditary hemochromatosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
254
|
56
|
0.040 |
None |
1.000 |
4 |
4
|
2012 |
2017 |
Juvenile hemochromatosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
18
|
8
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
HFE-Associated Hereditary Hemochromatosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
10
|
3
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
3 beta-Hydroxysteroid dehydrogenase deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
9
|
25
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |